Drug
Itraconazole
Itraconazole: highest development phase Phase 1, developed by Hutchmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hutchmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| Itraconazole 200 mg NCT05602597 | Phase 1 | Relapsed or Refractory Lymphoma |
Latest
No recent events.
Follow Itraconazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.